Indian pharma market reflects growth of 7 percent in year 2022

Published On 2023-03-09 13:15 GMT   |   Update On 2024-01-19 10:53 GMT
Advertisement

The Indian Pharmaceutical Market (IPM) has reflected growth of 7 percent in the year 2022 with overall IPM market size at Rs 1,93,838 crore Moving Annual Turnover (MAT), as per IQVIA.

As per the report, the growth in Sales Value was recorded at 7% (MAT), and Chronic TAs growth (9% MAT) outperformed Acute TAs growth (5% MAT) in 2022.

The relative performance of the Indian Pharma companies grew faster at 7% compared to MNCs which grew at 4% in 2022. Further, the number of new launches have increased by 2% to 3032 in 2022 as compared to 2021.

Advertisement

For more details, check out the link given below:

Indian Pharma Firms Grew Faster At 7 Percent Compared To 4 Percent Of MNCs In 2022: IQVIA


Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News